Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros

Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Geriatr Psychiatry ; 35(10): 1151-1155, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32419240

RESUMO

OBJECTIVE: The objective of this study was to predict rehospitalisation in a psychiatric clinic in older inpatients with a psychotic disorder. METHODS/DESIGN: In this prospective, observational study, all eligible inpatients aged 55 years and over with a primary psychotic disorder, admitted to a specialised ward for older psychotic patients in a large psychiatric inpatient clinic in the Netherlands, were asked to participate. Whether or not patients were rehospitalised and time to rehospitalisation were assessed 1 year after discharge from the ward. We recorded age, gender, living arrangement, psychiatric diagnosis, severity of psychotic symptoms, duration of index episode, age of onset of psychotic disorder, number of previous admissions, involuntary admission and use of depot medication at discharge. All patients underwent a neuropsychological assessment. RESULTS: Of the 90 patients that were included, 32 (35.6%) had been readmitted within 1 year after discharge. None of the demographic or clinical variables predicted rehospitalisation or the time to rehospitalisation. CONCLUSION: Factors that predict rehospitalisationin younger adult patients with schizophrenia may not predict rehospitalisationin older patients with a psychotic disorder, of which the majority suffered from schizophrenia. We expect that other factors than those investigated may be of greater importance to predict rehospitalisation, as for example social support and coping mechanisms.


Assuntos
Pacientes Internados , Transtornos Psicóticos , Idoso , Humanos , Países Baixos , Readmissão do Paciente , Estudos Prospectivos , Transtornos Psicóticos/terapia
2.
Biol Blood Marrow Transplant ; 25(3): 556-561, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30321596

RESUMO

Hematopoietic stem cell transplantation (HSCT) is a therapeutic option for many nonmalignant disorders (NMD) and is curative or prevents disease progression. Reduced-intensity conditioning (RIC) in HSCT for NMD may reduce regimen-related acute toxicities and late complications. Myeloablation is often replaced by immune suppression in RIC regimens to support donor engraftment. The pace of immune reconstitution after immune suppression by RIC regimens is influenced by agents used, donor source, and graft-versus-host disease prophylaxis/treatment. In a multicenter trial (NCT 00920972) of HSCT for NMD, a RIC regimen consisting of alemtuzumab, fludarabine, and melphalan was substituted for myeloablation. Alemtuzumab was administered early (days -21 to -19) to mitigate major lymphodepletion of the incoming graft and the risk of graft rejection. Immune reconstitution and infectious complications were prospectively monitored for 1-year post-HSCT. Seventy-one patients met inclusion criteria for this report and received marrow or peripheral blood stem cell transplants. Immune reconstitution and infections are reported for related donor (RD) and unrelated donor (URD) transplants at 3 time-points (100days, 6 months, and 1 year post-HSCT). Natural killer cell recovery was rapid, and numbers normalized in both cohorts by day +100. Mean CD3, CD4, and CD8 T-lymphocyte numbers normalized by 6 months after RD HSCT and by 1 year in the URD group. CD4 and CD8 T-lymphocyte counts were significantly higher in patients who received RD HSCT at 6 months and at 1 year, respectively, post-HSCT compared with patients who received URD HSCT. The pace of CD19 B-cell recovery was markedly different between RD and URD cohorts. Mean B-cell numbers were normal by day 100 after RD HSCT but took 1 year post-HSCT to normalize in the URD cohort. Despite these differences in immune reconstitution, the timing and nature of infections did not differ between the groups, presumably because of comparable T-lymphocyte recovery. Immune reconstitution occurred at a faster pace than in prior reports using RIC with T-cell depletion. The incidence of infections was similar for both cohorts and occurred most frequently in the first 100days post-HSCT. Viral and fungal infections occurred at a lower incidence in this cohort, with "early" alemtuzumab compared with regimens administering serotherapy in the peritransplantation period. Patients were susceptible to bacterial infections primarily in the first 100days irrespective of donor source and had no increase in mortality from the same. The overall mortality rate from infections was 1.4% at 1 year. Close monitoring and prophylaxis against bacterial infections in the first 100days post-HSCT is necessary but is followed by robust immune reconstitution, especially in the T-cell compartment.


Assuntos
Alemtuzumab/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/métodos , Reconstituição Imune , Infecções/etiologia , Condicionamento Pré-Transplante/métodos , Alemtuzumab/efeitos adversos , Criança , Feminino , Sobrevivência de Enxerto , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Depleção Linfocítica , Masculino , Análise de Sobrevida , Doadores não Relacionados
3.
J Sleep Res ; 27(5): e12670, 2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-29479768

RESUMO

Caffeine is often used to reduce sleepiness; however, research suggests that it can also cause poor sleep quality. The timing of caffeine use, amongst other factors, is likely to be important for the effects it has on sleep quality. In addition, individual differences exist in the effect of caffeine on sleep quality. This cross-sectional study investigated the influence of the timing of caffeine consumption on and a possible moderating role of chronotype in the relationship between caffeine consumption and sleep quality in 880 students (74.9% female, mean age 21.3 years, SD = 3.1). Respondents filled in online questionnaires about chronotype (the Morningness-Eveningness Questionnaire), sleep quality (the Pittsburgh Sleep Quality Index) and caffeine consumption. Mean caffeine consumption was 624 mg per week, and 80.2% of the sample drank caffeine after 18:00 hours. Regression analyses demonstrated that higher total caffeine consumption was only related to poorer sleep quality for people who did not drink caffeine in the evening (ß = 0.209, p = .006). We did not find a relationship between caffeine and sleep quality in people who drank caffeine in the evening (ß = -0.053, p = .160). Furthermore, we found no evidence for a moderating role of chronotype in the relationship between caffeine consumption and sleep quality. We concluded that a self-regulating mechanism is likely to play a role, suggesting that students who know that caffeine negatively affects their sleep quality do not drink it in the evening. Caffeine sensitivity and the speed of caffeine metabolism may be confounding variables in our study.


Assuntos
Cafeína/efeitos adversos , Ritmo Circadiano/efeitos dos fármacos , Distúrbios do Início e da Manutenção do Sono/fisiopatologia , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Estudantes , Inquéritos e Questionários , Fatores de Tempo , Adulto Jovem
4.
J Sleep Res ; 27(1): 40-46, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28618114

RESUMO

Insomnia symptoms are highly prevalent in depressed older adults. This study investigates the association between hypothalamic-pituitary-adrenal (HPA) axis activity and symptoms of insomnia, respectively, sleep duration among 294 depressed and 123 non-depressed older adults of the Netherlands Study of Depression in Older people (NESDO) study. Insomnia symptoms were defined as clinically relevant when having a score ≥ 10 points on the Women's Health Initiative Insomnia Rating Scale (WHIIRS). Sleep duration was categorized in short (≤ 6 h per night), normal (7-8 h per night) and long (≥ 9 h per night) duration. Salivary cortisol levels were used to assess the following cortisol parameters for HPA axis activity: area under the curve with respect to the increase (AUCi) and to the ground (AUCg), diurnal slope, evening cortisol level and dexamethasone suppression ratio. Clinically relevant insomnia symptoms were present in 46% of the participants. Thirty-two per cent of the participants were short sleepers, whereas 16% were long sleepers. However, univariate analyses showed no differences in any of the HPA axis parameters between people with and without insomnia symptoms or between the three groups with different sleep duration. In addition, no significant interaction was found between a diagnosis of depression or the severity of depressive symptoms and any of the cortisol parameters in relation to insomnia symptoms or sleep duration.


Assuntos
Autoavaliação Diagnóstica , Sistema Hipotálamo-Hipofisário/metabolismo , Sistema Hipófise-Suprarrenal/metabolismo , Distúrbios do Início e da Manutenção do Sono/metabolismo , Sono/fisiologia , Idoso , Idoso de 80 Anos ou mais , Depressão/diagnóstico , Depressão/epidemiologia , Depressão/metabolismo , Feminino , Humanos , Hidrocortisona/análise , Hidrocortisona/metabolismo , Masculino , Países Baixos/epidemiologia , Saliva/química , Saliva/metabolismo , Distúrbios do Início e da Manutenção do Sono/diagnóstico , Distúrbios do Início e da Manutenção do Sono/epidemiologia
5.
Am J Geriatr Psychiatry ; 26(4): 419-434, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29107460

RESUMO

OBJECTIVES: Many patients with dementia develop agitation or aggression in the course of their disease. In some severe cases, behavioral, environmental, and pharmacological interventions are not sufficient to alleviate these potentially life-threatening symptoms. It has been suggested that in those cases, electroconvulsive therapy (ECT) could be an option. This review summarizes the scientific literature on ECT for agitation and aggression in dementia. METHODS: We performed a systematic review in accordance with PRISMA guidelines. A search was conducted in Ovid MEDLINE, EMBASE, and PsycINFO. Two reviewers extracted the following data from the retrieved articles: number of patients and their age, gender, diagnoses, types of problem behavior, treatments tried before ECT, specifications of the ECT treatment, use of rating scales, treatment results, follow-up data, and adverse effects. RESULTS: The initial search yielded 264 articles, 17 of which fulfilled the inclusion criteria. Of these studies, one was a prospective cohort study, one was a case-control study, and the others were retrospective chart reviews, case series, or case reports. Clinically significant improvement was observed in the majority (88%) of the 122 patients described, often early in the treatment course. Adverse effects were most commonly mild, transient, or not reported. CONCLUSIONS: The reviewed articles suggest that ECT could be an effective treatment for severe and treatment-refractory agitation and aggression in dementia, with few adverse consequences. Nevertheless, because of the substantial risk of selection bias, the designs of the studies reviewed, and their small number, further prospective studies are needed to substantiate these preliminary positive results.


Assuntos
Demência/terapia , Eletroconvulsoterapia/métodos , Agitação Psicomotora/terapia , Demência/psicologia , Eletroconvulsoterapia/efeitos adversos , Humanos , Agitação Psicomotora/etiologia , Psicotrópicos/uso terapêutico , Qualidade de Vida , Resultado do Tratamento
6.
Int J Geriatr Psychiatry ; 33(7): 1000-1008, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-29691948

RESUMO

OBJECTIVES: To investigate whether lifestyle indicators including physical exercise, sleep duration, alcohol use, body mass index, smoking status, and a composite lifestyle index are associated with the depression course in older adults. METHODS: Data of 283 older adults were used from the Netherlands Study of Depression in Older Persons. Depressive disorders at baseline were assessed with the Composite International Diagnostic Interview. The depression course at 2-year follow-up was assessed with the Inventory of Depressive Symptoms (IDS, score 0-84) every 6 months; physical exercise with the International Physical Activity Questionnaire; alcohol use with the Alcohol Use Disorders Identification Test; body mass index by anthropometry; and sleep duration and smoking status by interview questions. A composite lifestyle index was calculated by summing scores assigned to each lifestyle factor, with a higher score indicating healthier behavior. RESULTS: Of all participants, 61.1% had chronic depression (all IDS scores 14-84), 20.1% had intermittent depression (1 IDS score ≤ 14), and 18.7% remitted depression (last 2 IDS scores ≤14). None of the investigated lifestyle indicators, nor the composite lifestyle index was associated with depression course, after adjustment for covariates. CONCLUSIONS: Lifestyle factors do not predict the course of depression at 2-year follow-up in older adults.


Assuntos
Transtorno Depressivo/epidemiologia , Estilo de Vida , Idoso , Consumo de Bebidas Alcoólicas/efeitos adversos , Índice de Massa Corporal , Estudos de Casos e Controles , Transtorno Depressivo/diagnóstico , Exercício Físico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Fatores de Risco , Sono/fisiologia , Fumar/efeitos adversos
7.
Int J Geriatr Psychiatry ; 33(2): 371-378, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-28657697

RESUMO

OBJECTIVE: Research suggests that in depression, vascular burden predicts a lower efficacy for medication (MED) and a more favourable outcome for electroconvulsive therapy (ECT). Therefore, we investigated the influence of the following vascular risk factors (VRF): hypercholesterolemia, hypertension, smoking, diabetes mellitus, cardiovascular disease, and cerebral vascular accident/transient ischemic attack, on remission from major depression after ECT versus MED. METHODS: The study sample consisted of 81 inpatients with a DSM-IV unipolar major depression diagnosis (mean age 72.2 years, SD = 7.6, mean Montgomery-Åsberg Depression Rating Scale score 32.9, SD = 6.2) participating in a randomized controlled trial comparing nortriptyline versus venlafaxine and 43 inpatients (mean age 73.7 years, SD = 7.5, mean Montgomery-Åsberg Depression Rating Scale score 30.6, SD = 7.1) from an randomized controlled trial comparing brief pulse versus ultrabrief pulse ECT. The presence of VRF was established from the medical records. The remission rate of patients with VRF was compared with those of patients without VRF. RESULTS: The remission rate was 58% (19/33) in the ECT group with ≥1 VRF and 32% (23/73) in the MED group with ≥1 VRF (χ2  = 6.456, p = 0.011). Comparing patients with no VRF versus ≥1 VRF, the remission rate decreased from 80 to 58% (χ2  = 1.652, p = 0.276) in ECT patients and from 38 to 32% (χ2  = 0.119, p = 0.707) in MED patients. Applying different cut-offs for the number of VRFs yielded the same trends. Logistic regression revealed no interaction between VRF and treatment condition. CONCLUSION: The superior efficacy of ECT over pharmacotherapy in major depression in older age was independent of the presence of VRF. Copyright © 2017 John Wiley & Sons, Ltd.


Assuntos
Antidepressivos de Segunda Geração/uso terapêutico , Transtorno Depressivo Maior/terapia , Eletroconvulsoterapia , Inibidores da Recaptação de Serotonina e Norepinefrina/uso terapêutico , Doenças Vasculares/complicações , Idoso , Idoso de 80 Anos ou mais , Transtorno Depressivo Maior/tratamento farmacológico , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Nortriptilina/uso terapêutico , Fatores de Risco , Resultado do Tratamento , Cloridrato de Venlafaxina/uso terapêutico
8.
Aging Ment Health ; 22(2): 233-238, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27827534

RESUMO

OBJECTIVES: Sleep disturbances are common among depressed older persons. To gain insight into sleep disturbances in late-life depression, their occurrence and correlates were assessed. METHODS: Baseline data of 294 depressed older persons of the Netherlands Study of Depression in Older persons study were used. A diagnosis of current depression according to the diagnostic and statistical manual of mental disorders-IV (DSM-IV) was assessed with the Composite International Diagnostic Interview. Sleep disturbances were measured with the five-item Women's Health Initiative Insomnia Rating Scale, and considered present with a score of ≥10 points. RESULTS: Sleep disturbances were present in 59.9% of the depressed older persons. Bivariate linear regression analyses showed that presence of sleep disturbances was associated with fewer years of education, use of alcohol, the number of chronic diseases, higher pain intensity scores, use of more benzodiazepines, more anxiety and severity of depressive symptoms. In multivariate analyses, severity of depression appeared to be the only independent correlate. CONCLUSIONS: Sleep disturbances are highly prevalent in patients with late-life depression and independently correlated with the severity of depression. Treatment of depression may result in improvement of sleep disturbances, although cognitive behavioral interventions that focus on both depression and sleep disturbances may also be effective.


Assuntos
Antidepressivos/uso terapêutico , Ansiedade , Terapia Cognitivo-Comportamental/métodos , Depressão , Transtornos do Sono-Vigília , Idade de Início , Idoso , Ansiedade/diagnóstico , Ansiedade/psicologia , Depressão/diagnóstico , Depressão/epidemiologia , Depressão/psicologia , Depressão/terapia , Manual Diagnóstico e Estatístico de Transtornos Mentais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos/epidemiologia , Escalas de Graduação Psiquiátrica , Fatores de Risco , Transtornos do Sono-Vigília/diagnóstico , Transtornos do Sono-Vigília/epidemiologia , Transtornos do Sono-Vigília/etiologia , Transtornos do Sono-Vigília/psicologia , Fatores Socioeconômicos
9.
Subst Use Misuse ; 52(5): 574-580, 2017 04 16.
Artigo em Inglês | MEDLINE | ID: mdl-28033476

RESUMO

BACKGROUND: Alcohol dependence is associated with impairments in cognition, especially in later life. Previous studies suggest that excessive drinking has more negative impact on cognition in women than in men. OBJECTIVES: In this study, differences in cognition between male and female older, alcohol-dependent patients were examined. METHOD: Older alcohol-dependent inpatients (N = 164, 62.2% men, mean age 62.6 ± 6.4) underwent neuropsychological tests of sensitivity to interference, mental flexibility, and visual processing. RESULTS: No gender differences were found in age, educational level, estimated premorbid verbal intelligence, and sensitivity to interference. Duration of alcohol dependence was longer for men than for women. Men performed better than women on visual processing, and women better than men on mental flexibility. The superior mental flexibility of women remained significant after adjustment for duration of alcohol dependence. Conclusions/Importance: Older alcohol-dependent inpatients performed below average on cognitive tasks, which suggests that long-term excessive alcohol use negatively affects cognition. Our study does not demonstrate more severe cognitive impairment in women than in men.


Assuntos
Alcoolismo/psicologia , Cognição , Fatores Etários , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Fatores Sexuais
10.
Br J Psychiatry ; 206(1): 67-71, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25323140

RESUMO

BACKGROUND: Severe depression can be a life-threatening disorder, especially in elderly patients. A fast-acting treatment is crucial for this group. Electroconvulsive therapy (ECT) may work faster than medication. AIMS: To compare the speed of remission using ECT v. medication in elderly in-patients. METHOD: The speed of remission in in-patients with a DSM-IV diagnosis of major depression (baseline MADRS score ≥20) was compared between 47 participants (mean age 74.0 years, s.d. = 7.4) from an ECT randomised controlled trial (RCT) and 81 participants (mean age 72.2 years, s.d. = 7.6) from a medication RCT (nortriptyline v. venlafaxine). RESULTS: Mean time to remission was 3.1 weeks (s.d. = 1.1) for the ECT group and 4.0 weeks (s.d. = 1.0) for the medication group; the adjusted hazard ratio for remission within 5 weeks (ECT v. medication) was 3.4 (95% CI 1.9-6.2). CONCLUSIONS: Considering the substantially higher speed of remission, ECT deserves a more prominent position in the treatment of elderly patients with severe depression.


Assuntos
Cicloexanóis/uso terapêutico , Transtorno Depressivo Maior/tratamento farmacológico , Transtorno Depressivo Maior/terapia , Eletroconvulsoterapia , Nortriptilina/uso terapêutico , Idoso , Antidepressivos de Segunda Geração/uso terapêutico , Feminino , Humanos , Masculino , Indução de Remissão , Fatores de Tempo , Resultado do Tratamento , Cloridrato de Venlafaxina
11.
Am J Addict ; 24(7): 661-6, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26300471

RESUMO

BACKGROUND AND OBJECTIVES: Alcohol dependence is often a chronic relapsing disorder with frequent admissions to inpatient facilities. This study in older alcohol-dependent inpatients investigates the role of social factors in readmissions after inpatient detoxification. METHODS: In a prospective study, 132 older alcohol-dependent patients admitted to inpatient detoxification (mean age 63.4, SD = 6.6, 39.4% women) were interviewed with the European version of the Addiction Severity Index (Europ-ASI). Readmission to inpatient treatment was monitored up to 1 year after discharge. The effect of social factors on readmission, the number of readmissions and the time to first readmission was established using group comparisons, Poisson regression analysis, and Cox' proportional hazards regression analysis, respectively. RESULTS: Sixty-seven (50.8%) of the 132 patients were readmitted within 1 year. In this group, the median number of readmissions was 2 (IQR = 2, range 1-6) and the median time to first readmission was 88 days (IQR = 116, range 3-356). In a multivariate analysis, spending most leisure time alone predicted fewer readmissions. None of the other social factors predicted readmission, number of readmissions or time to first readmission. DISCUSSION AND CONCLUSIONS: Rehospitalization of older alcohol-dependent patients after detoxification is very common, and generally not predicted by social factors. Only spending most leisure time alone may play a role. SCIENTIFIC SIGNIFICANCE: This study shows that most social factors are-unexpectedly-not associated with rehospitalization of older alcohol-dependent patients after detoxification. "Spending leisure time alone" warrants further study as a potentially modifiable predictor.


Assuntos
Alcoolismo/epidemiologia , Alcoolismo/psicologia , Pacientes Internados/psicologia , Pacientes Internados/estatística & dados numéricos , Readmissão do Paciente/estatística & dados numéricos , Comportamento Social , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Alcoolismo/reabilitação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Países Baixos/epidemiologia , Estudos Prospectivos , Fatores de Tempo
12.
Am J Geriatr Psychiatry ; 22(9): 866-74, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23891365

RESUMO

OBJECTIVES: To compare alcohol use between depressed and nondepressed older adults, and to investigate correlates of alcohol abstinence and at-risk alcohol consumption in depressed older adults. DESIGN: Cross-sectional study. SETTING: Netherlands Study of Depression in Older Persons (NESDO). PARTICIPANTS: A total of 373 participants (mean [standard deviation] age: 70.6 [7.3] years; 66% women) diagnosed with a depressive disorder, and 128 nondepressed participants. MEASUREMENTS: Alcohol use was assessed with the Alcohol Use Disorders Identification Test (AUDIT). Participants were categorized into abstainers (AUDIT score: 0), moderate drinkers (AUDIT score: 1-4), and at-risk drinkers (AUDIT score: ≥5). Multinomial logistic regression analysis was performed with AUDIT categories as outcome, and demographic, social, somatic, and psychological variables as determinants. RESULTS: The depressed group consisted of 40.2% abstainers, 40.8% moderate drinkers, and 19.0% at-risk drinkers. The depressed participants were more often abstinent and less often moderate drinkers than the nondepressed participants; they did not differ in at-risk drinking. Depressed abstainers more often used benzodiazepines but less often used antidepressants, and they had a poorer cognitive function than depressed moderate drinkers. Depressed at-risk drinkers were more often smokers and had fewer functional limitations but more severe depressive symptoms than depressed moderate drinkers. CONCLUSIONS: Although alcohol abstinence was more common in depressed than in nondepressed older adults, 19% of depressed persons were at-risk drinkers. Because at-risk drinking is associated with more severe depression and may have a negative impact on health and treatment outcome, it is important that physicians consider alcohol use in depressed older adults.


Assuntos
Envelhecimento/psicologia , Abstinência de Álcool/psicologia , Consumo de Bebidas Alcoólicas/psicologia , Transtorno Depressivo/psicologia , Idoso , Estudos de Casos e Controles , Cognição , Estudos Transversais , Feminino , Inquéritos Epidemiológicos , Humanos , Masculino , Países Baixos
13.
Int Psychogeriatr ; 26(11): 1863-9, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24832056

RESUMO

BACKGROUND: Alcohol dependence in older adults is associated with cognitive impairment. Age of onset of alcohol dependence is an important criterion to distinguish subgroups of alcohol-dependent people. Little is known about the influence of the age of onset of alcohol dependence on cognitive functioning. The primary aim of this study was to examine if older alcohol-dependent people with early, late or very late onset of alcohol dependence differ in terms of cognitive dysfunction. METHODS: A total of eighty-five older alcohol-dependent people who were admitted to an inpatient detoxification program, were categorized into three age of onset groups: early onset (< 25 years: N = 27, mean age 57.7 ± 7.4), late onset (25-44 years: N = 28, mean age 61.1 ± 6.7) and very late onset (≥ 45 years: N = 30, mean age 65.6 ± 6.5). A neuropsychological test battery (Kaufman-Short Neuropsychological Assessment Procedure (K-SNAP), Trail Making Test (TMT) and Stroop Color Word Test) was administered to assess cognitive functioning. Differences between groups were examined with analyses of variance (ANOVAs). RESULTS: There were no significant differences in performance on any of the neuropsychological measures between the three age of onset groups. However, compared to a non-alcohol-dependent norm group, all three age of onset groups performed below average. CONCLUSIONS: The results suggest that older adults who start drinking heavily (very) late in life have similar cognitive impairments compared to their peers who have been drinking for decades. This emphasizes the vulnerability of the aging brain to the toxic effects of alcohol.


Assuntos
Alcoolismo/psicologia , Transtornos Cognitivos/induzido quimicamente , Adulto , Idade de Início , Idoso , Alcoolismo/complicações , Cognição/efeitos dos fármacos , Feminino , Humanos , Masculino , Memória de Curto Prazo/efeitos dos fármacos , Pessoa de Meia-Idade , Testes Neuropsicológicos , Teste de Stroop , Adulto Jovem
14.
Eur Addict Res ; 20(5): 226-32, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24776814

RESUMO

AIMS: Age of onset is an important criterion to distinguish subgroups of alcohol-dependent patients. This study investigated physical and mental health and social functioning of older inpatients with early (age <25), late (25-44), and very late (≥45) onset of alcohol dependence. METHODS: In a specialized detoxification ward for older patients in The Hague, the Netherlands, 157 older alcohol-dependent inpatients (38% women, mean age 62.7 ± 6.5) were interviewed with the European version of the Addiction Severity Index. RESULTS: As a group, older alcohol-dependent patients had substantial physical, mental and social problems, which were largely independent of the age of onset of alcohol dependence. Patients with early-onset alcohol dependence had more chronic medical problems and more suicidal thoughts than patients with late-onset alcohol dependence. The very-late-onset group did not significantly differ from the other two groups in any of the variables under study. CONCLUSIONS: Despite previous studies showing more favourable outcomes for the (very) late-onset compared to the early-onset alcohol-dependent group, their comorbid (mental) health and social problems are in many respects similar, and require careful assessment and treatment. This may be crucial for successful treatment and improving quality of life in these patients.


Assuntos
Alcoolismo/psicologia , Saúde Mental , Qualidade de Vida/psicologia , Ajustamento Social , Adolescente , Adulto , Fatores Etários , Idade de Início , Idoso , Feminino , Nível de Saúde , Humanos , Pacientes Internados , Masculino , Pessoa de Meia-Idade , Adulto Jovem
15.
Clin Psychol Psychother ; 20(1): 49-54, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-21774036

RESUMO

In clinical practice, the combination of brief, cost effective, valid and reliable assessment of personality disorders (PDs) is highly important. Substantial budget cuts require optimal use of the clinician's time. PDs are related with high axis I comorbidity, poorer therapy outcome and increased health service costs. In an effort to find a screening questionnaire that meets both the demands of cost-effectiveness and methodological soundness, we investigated the use of the Personality Diagnostic Questionnaire 4+ (PDQ-4+) as a first step in a two-step diagnostic procedure. As the second step, we used the Structured Clinical Interview of DSM-IV Axis II Personality Disorders (SCID-II) as criterion measure. Our results show that the positive predictive power of the PDQ-4+ is rather low, resulting in a large number of false positives. Therefore, its added value is poor in comparison with administering the SCID-II in the first place. Also, the value of the two validity scales of the PDQ-4+ is highly questionable. We therefore conclude that the PDQ-4+ should not be used in clinical practice as a screening instrument for PD assessment.


Assuntos
Medicina Clínica/métodos , Programas de Rastreamento/métodos , Transtornos da Personalidade/diagnóstico , Inventário de Personalidade/normas , Inquéritos e Questionários/normas , Adulto , Feminino , Humanos , Entrevista Psicológica/métodos , Masculino , Programas de Rastreamento/normas , Transtornos da Personalidade/psicologia , Inventário de Personalidade/estatística & dados numéricos , Valor Preditivo dos Testes , Escalas de Graduação Psiquiátrica/estatística & dados numéricos , Psicometria , Reprodutibilidade dos Testes
16.
Sex Reprod Healthc ; 33: 100757, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36031703

RESUMO

The present study examined the thoughts and feelings of solo mothers by choice (SMC) regarding their experiences during pregnancy and early parenthood, with special focus on their contact with maternal health-services (MCHS). Semi-structured interviews were carried out with solo mothers (N = 10) who had undergone assisted fertilization in Sweden. Thematic analysis revealed two main themes. The first theme, "Strong individual, vulnerable group", illustrated a perception among participants that, although SMC as a group are vulnerable, they themselves are strong and do not identify with this vulnerability. It is thus conceivable that staff in MCHS may not detect the vulnerability and needs of these women who have strong incentives to present themselves as strong and competent. The second theme, "Same but different", reflected the participants' conflicting needs to be treated like everyone else within the MCHS while at the same time wishing for adaptations of the healthcare services' praxis so that it better suits their needs as solo mothers. These themes illustrate what may be considered as paradoxical expectations and unreasonable needs in the participants' contacts with the MCHS, but they also highlight how social attitudes can have an impact on these parents' individual experiences of healthcare. Because contact with MCHS takes place during a vulnerable period, particular sensitivity and compassionate attention may be needed in order to encourage these women to bring their needs forward.


Assuntos
Serviços de Saúde Materna , Saúde Materna , Emoções , Feminino , Humanos , Mães , Pais , Gravidez , Pesquisa Qualitativa
17.
Psychiatry Clin Psychopharmacol ; 32(3): 188-195, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38766672

RESUMO

Background: Despite the frequent co-occurrence of posttraumatic stress disorder and substance use disorder, screening for trauma exposure and posttraumatic stress disorder symptoms is not a routine practice in substance use disorder clinics. The aims of this study were to examine the prevalence of exposure to traumatic events, posttraumatic stress disorder symptoms, and subjective sleep quality in substance use disorder inpatients after detoxification. In addition, we analyzed associations of sociodemographics, direct and indirect exposure to traumatic events, and sleep quality with posttraumatic stress disorder symptom severity. Methods: Adults diagnosed with substance use disorder (n = 188; 25% women, mean age 46.6 ± 12.3 years) from 2 inpatient addiction clinics were assessed at approximately 4 days post-admission for age, gender, educational level, self-reported substance use, trauma exposure, general and posttraumatic stress disorder-specific subjective sleep quality, and posttraumatic stress disorder symptom severity. Correlates of posttraumatic stress disorder symptom severity were identified with linear regression analyses. Results: The prevalence of direct trauma exposure was high (89%), 51% of participants screened positive for posttraumatic stress disorder and 87% reported clinically significant poor sleep quality. Younger age, female gender, direct and indirect exposure to more traumatic events, and poor subjective sleep quality were associated with more severe posttraumatic stress disorder symptoms. Conclusion: Nearly all substance use disorder patients admitted for detoxification in our study had been directly or indirectly exposed to 1 or more traumatic events, and many reported posttraumatic stress disorder symptoms and poor sleep quality. Younger and female substance use disorder patients were at higher risk of posttraumatic stress disorder symptoms. Our results emphasize the need for systematic screening for direct and indirect trauma exposure, posttraumatic stress disorder symptoms, and poor sleep quality in patients admitted for clinical substance use disorder treatment.

18.
J Clin Psychopharmacol ; 31(1): 45-50, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21192142

RESUMO

The hypothesis that ß-blockers cause depression has been both confirmed and refuted in previous studies. However, in hardly any of these studies, depression was systematically and adequately assessed. The aim of this cohort study was to examine whether ß-blockers, in general, highly lipid-soluble, nonselective, or serotonergic receptor-binding ß-blockers, are associated with incident depression. Between 1993 and 2005, 5104 elderly persons were followed for incident depressions. Depressions were identified by regular interview and continuous monitoring of medical records. Cases were categorized as clinically relevant depressive symptoms or as depressive syndromes, the latter including Diagnostic and Statistical Manual of Mental Disorders-IV-defined depressive disorders. Pharmacies provided information on filled ß-blockers. We used Cox regression with drug use as a time-dependent variable to analyze the data, adjusted for potential demographic covariates, activity of daily living, and (contra)indications for ß-blockers. We found that use of ß-blockers in general did not convey an increased risk of depressive symptoms (hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.37-1.59) or depressive syndromes (HR, 0.99; 95% CI, 0.53-1.84). Highly lipid-soluble ß-blockers, mostly propranolol in our study, were associated with depressive symptoms during the first 3 months of use (HR, 3.31; 95% CI, 1.03-10.6), but not with depressive syndromes. Nonselective or serotonergic receptor affinity was not associated with an increased risk of depressive symptoms or syndromes independent of high lipid solubility. We conclude that ß-blockers in general do not convey an increased risk of depression. Lipophilic ß-blockers are associated with an increased risk of depressive symptoms.


Assuntos
Antagonistas Adrenérgicos beta/efeitos adversos , Depressão/induzido quimicamente , Depressão/epidemiologia , Fatores Etários , Idoso , Envelhecimento/efeitos dos fármacos , Envelhecimento/fisiologia , Estudos de Coortes , Depressão/psicologia , Feminino , Seguimentos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco
20.
Sleep ; 32(10): 1367-75, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19848365

RESUMO

STUDY OBJECTIVES: To investigate and explain sex differences in subjective and actigraphic sleep parameters in community-dwelling elderly persons. DESIGN: Cross-sectional study. SETTING: The study was embedded in the Rotterdam Study, a population-based study. PARTICIPANTS: Nine hundred fifty-six participants aged 59 to 97 years. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: Participants wore an actigraph and kept a sleep diary for an average of 6 consecutive nights. Subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index. Unadjusted sex differences in sleep parameters were assessed with t tests. Women reported shorter total sleep time, a less favorable sleep-onset latency, lower sleep efficiency, and worse global sleep quality, as compared with men. When assessed with actigraphy, however, women were found to have longer and less-fragmented sleep than men. Sex differences in diary-reported sleep duration and other subjective sleep parameters were attenuated by adjustment for marital status, the use of sleep medication, and other covariates, but all sex differences remained significant in a multivariate-adjusted model. Sex differences in actigraphic sleep parameters were barely attenuated by multivariate adjustment, although the shorter actigraphically measured sleep duration in men was partly explained by their higher alcohol consumption. Some covariates (eg, sleep medication) had a different relationship with diary-reported or actigraphic total sleep time in men and women. CONCLUSIONS: If assessed by diary or interview, elderly women consistently reported shorter and poorer sleep than elderly men. In contrast, actigraphic sleep measures showed poorer sleep in men. These discrepancies are partly explained by determinants of sleep duration, such as sleep medication use and alcohol consumption.


Assuntos
Actigrafia/estatística & dados numéricos , Avaliação Geriátrica/estatística & dados numéricos , Transtornos do Sono-Vigília/diagnóstico , Actigrafia/métodos , Idoso , Idoso de 80 Anos ou mais , Transtornos de Ansiedade/complicações , Estudos de Coortes , Estudos Transversais , Transtorno Depressivo/complicações , Feminino , Avaliação Geriátrica/métodos , Nível de Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Países Baixos , Autorrevelação , Fatores Sexuais , Transtornos do Sono-Vigília/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA